Literature DB >> 10891815

Airway nitrogen oxide measurements in asthma and other pediatric respiratory diseases.

J Hunt1, B Gaston.   

Abstract

Markers for airway inflammation that can be measured noninvasively in expired air may be helpful in treating patients with asthma. For example, levels of nitric oxide are high in the breath of children with asthma exacerbations and decrease with anti-inflammatory therapy. Expired nitric oxide testing has now been standardized and may be useful for children with recurring wheezing that is diagnostically or therapeutically challenging. However, the results may be influenced by several biochemical and anatomic variables and must therefore be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891815     DOI: 10.1067/mpd.2000.107526

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Tidal off-line exhaled nitric oxide measurements in a pre-school population.

Authors:  Isabelle Meyts; Marijke Proesmans; Veerle Van Gerven; Karel Hoppenbrouwers; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2003-05-09       Impact factor: 3.183

2.  S-nitrosoglutathione reductase: an important regulator in human asthma.

Authors:  Loretta G Que; Zhonghui Yang; Jonathan S Stamler; Njira L Lugogo; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2009-04-24       Impact factor: 21.405

3.  Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.

Authors:  Nives Zimmermann; Nina E King; Johanne Laporte; Ming Yang; Anil Mishra; Sam M Pope; Emily E Muntel; David P Witte; Anthony A Pegg; Paul S Foster; Qutayba Hamid; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 4.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.